Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.

Saved in:
Bibliographic Details
Title: Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.
Authors: Cantillo E; Weill Cornell Medicine, New York, NY., Podder V; Mount Sinai Medical Center, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Miami Beach, FL., Danziger N; Foundation Medicine, Inc, Boston, MA., Lobo D; University of Cincinnati Cancer Center, Cincinnati, OH., Lin DI; Foundation Medicine, Inc, Boston, MA., Graf RP; Foundation Medicine, Inc, Boston, MA., Coleman RL; US Oncology Research, The Woodlands, TX., Pothuri B; New York University Langone Health, New York, NY., Eskander RN; University of California San Diego, Rebecca and John Moores Cancer Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, San Diego, CA., Herzog TJ; University of Cincinnati Cancer Center, Cincinnati, OH., Slomovitz BM; Mount Sinai Medical Center, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Miami Beach, FL.
Source: JCO precision oncology [JCO Precis Oncol] 2026 Jul; Vol. 10 (7), pp. e2501157. Date of Electronic Publication: 2026 Jul 10.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO-25-01157